The HSPG binding peptide blocked VEGF binding to human liposarcoma cells, ASPC-1 cells to more than 99% and VEGF binding of HUVECs to 96% at high concentration (10 μg/ml) (Fig. 1A). Here, VEGFA is linked to liposarcoma.